Inflammation, immunity, and hypertensive end-organ damage

Area of Science:

• Immunology
• Cardiovascular Science
• Nephrology

Background:

• Immunity has long been linked to hypertension.
• Recent research highlights T cells and cytokines in experimental hypertension models.

Purpose of the Study:

• To elucidate the role of immune system components in hypertension.
• To explore the link between oxidative stress and immune activation in hypertension.
• To identify potential therapeutic targets within the immune system for hypertension management.

Main Methods:

• Investigated T cell infiltration and cytokine release (IL-17, IFN-γ, TNF-α, IL-6) in response to hypertensive stimuli (Ang II, DOCA-salt, catecholamines).
• Examined monocyte/macrophage accumulation in renal and vascular tissues.
• Studied the role of oxidative stress, reactive oxygen species, and neoantigen formation in dendritic cells leading to T cell activation.

Main Results:

• Hypertension stimuli promote effector T cell and monocyte/macrophage infiltration in kidneys and vasculature.
• Immune-derived cytokines (IL-17, IFN-γ, TNF-α, IL-6) induce renal and vascular dysfunction, sodium retention, and increased vascular resistance.
• Oxidative stress in dendritic cells generates neoantigens that activate T cells, promoting hypertension.
• Both innate and adaptive immune cells contribute to end-organ damage in hypertension.

Conclusions:

• Immune system activation, involving T cells, cytokines, and oxidative stress-induced neoantigens, plays a critical role in hypertension pathogenesis and end-organ damage.
• Therapeutic strategies targeting immune cell activation hold promise for managing hypertension and preventing associated cardiovascular and renal complications.